zaijan The Nigerian All-Share Index (ASI) concluded the trading session on November 25, 2024, on a subdued note, slipping by 202.75 points to settle at 97,626.27, a modest decline of 0.21%. Amid the downturn, the market witnessed a notable surge in activity, with trading volume soaring by an impressive 83.33%. A total of 671 million shares exchanged hands, a sharp increase from the previous day’s 366 million shares, underscoring heightened participation on the trading floor. Related Stories Weekly Market Wrap: All-Share Index rises by 106.74 points as John Holt gains 42.49%, Multiverse tops losers Market Wrap: All-Share Index dips 0.17% as EUNISELL soars to lead gainers On the gainers’ chart, HMCALL rose by 10.00% to claim the top spot as the day’s best-performing stock. SUNUASSUR followed with a 9.81% increase, while NCR secured the third position with a rise of 9.72%. On the flip side, NSLTECH topped the losers’ chart, dropping by 9.84%, while DAARCOMM followed closely with a decline of 9.68%. FBN Holdings (FBNH) and HMCALL dominated market activity as the most actively traded stocks of the day, showcasing robust performance and sustained investor interest despite the overall market’s subdued tone. Current ASI: 97,626.27 points Previous ASI: 97,829.02 points Day Change: -0.21% Year-to-Date Performance: +30.56% Volume Traded: 671 million shares Deals: 10,464 HMCALL: up 10.00% to N5.61 SUNUASSUR: up 9.81% to N3.47 NCR: up 9.72% to N4.74 SOVRENINS: up 9.52% to N0.69 TANTALIZER: up 9.32% to N1.29 NSLTECH: down 9.84% to N0.55 DAARCOMM: down 9.68% to N0.56 AUSTINLAZ: down 9.40% to N2.41 GUINEANS: down 9.09% to N0.50 LASACO: down 8.63% to N2.33 The Nigerian equities market saw a notable surge in activity, with trading volume rising by an impressive 83.33%. Investors exchanged a total of 671 million shares, a substantial increase from the 366 million shares recorded in the previous session. FBN Holdings (FBNH) led the charge, with a staggering 245.2 million shares changing hands, firmly establishing itself as the most actively traded stock of the day. Following closely was HMCALL, which recorded a solid 47.1 million shares traded. Other significant contributors to the trading volume included TANTALIZER with 35.3 million shares, GUINEAINS at 32.8 million shares, and PRESTIGE, rounding out the top five with 32.7 million shares. On the value front, FBNH dominated once again, driving transactions worth an impressive N6.2 billion. UBA followed with trade values totalling N640.6 million, highlighting continued investor interest. ZENITHBANK and WAPCO also attracted significant attention, contributing N423.4 million and N290.9 million, respectively, to the day’s trading value. HMCALL completed the top five with N264.4 million in transactions, reinforcing its strong appeal to market participants. In the SWOOT category, which features stocks with market capitalizations exceeding N1 trillion, OANDO stood out as the sole gainer, advancing by 2.50%. The FUGAZ stocks, comprising FBN Holdings (FBNH), United Bank for Africa (UBA), Access Holdings (ACCESSCORP), and Zenith Bank (ZENITHBANK), closed the session in negative territory. GTCO led the declines, shedding 3.39%, followed by ZENITHBANK and FBNH, which lost 2.71% and 1.57%, respectively. UBA remained unchanged, maintaining a flat close. Outlook Despite the market’s slight decline, optimism persists for a rebound in the Nigerian equities market. Strong Q3 earnings across several sectors, coupled with sustained investor interest, are expected to drive upward momentum in the coming sessions.— Court Rules in Favor of Heron in Patent Lawsuit Against Fresenius Kabi USA , LLC — SAN DIEGO , Dec. 3, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the U.S. District Court for the District of Delaware ruled in Heron's favor in the Company's patent litigation against Fresenius Kabi USA , LLC with respect to CINVANTI® (aprepitant) injectable emulsion. The district court found that Heron's U.S. Patent Nos. 9,561,229 and 9,974,794, which expire in 2035, are valid and would be infringed by Fresenius' proposed generic product. The district court decision concludes the litigation initiated in July 2022 in response to Fresenius' submission of an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval of a generic version of CINVANTI®. As a result of the decision, Heron will seek an order from the Court prohibiting Fresenius from launching its generic CINVANTI® until after the expiration of the patents in 2035. This decision is subject to appeal. "We are pleased with this anticipated result of the proceeding and will continue to vigorously defend the CINVANTI® patent estate in the future," said Craig Collard, Chief Executive Officer of Heron. "The team at Heron takes great pride in the result of our successful history of developing injectable products, which is demonstrated by the strength of our intellectual property and the performance of our innovative drugs like CINVANTI® in serving patients with serious unmet needs." About Heron Therapeutics, Inc. Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com . Forward-looking Statements This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. Therefore, you should not place undue reliance on forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors." Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law. Investor Relations and Media Contact: Ira Duarte Executive Vice President, Chief Financial Officer Heron Therapeutics, Inc. iduarte@herontx.com 858-251-4400 View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-upholds-validity-of-cinvanti-patents-302321651.html SOURCE Heron Therapeutics, Inc.

Saquon Barkley became the ninth running back in NFL history to rush for 2,000 yards in a single season as the Philadelphia Eagles clinched the NFC East title with victory over the Dallas Cowboys. The 27-year-old achieved the feat with a 23-yard run during the fourth quarter of the Eagles’ crushing 41-7 success at Lincoln Financial Field. Barkley is 100 yards short of Eric Dickerson’s record of 2,105 yards, set in 1984 for the Los Angeles Rams, ahead of next week’s regular season finale against the New York Giants. However, he could be rested for that game in order to protect him from injury ahead of the play-offs. The Tampa Bay Buccaneers kept alive their dreams of reaching the play-offs by overcoming the Carolina Panthers 48-14. Veteran quarterback Baker Mayfield produced a dominant performance at Raymond James Stadium, registering five passing touchdowns to equal a Buccaneers franchise record. The Buffalo Bills clinched the AFC conference number two seed for the post season with a 40-14 success over the New York Jets at Highmark Stadium. Josh Allen passed for 182 yards and two touchdowns, while rushing for another. Buffalo finish the 2024 regular season undefeated at home, with eight wins from as many games. The Indianapolis Colts’ hopes of reaching the play-offs were ended by a 45-33 defeat to the Giants. Malik Nabers exploded for 171 yards and two touchdowns and Ihmir Smith-Marsette broke a 100-yard kick-off return to give the Giants their highest-scoring output under head coach Brian Daboll. Quarterback Drew Lock threw four touchdown passes and accounted for a fifth on the ground to seal the win. Elsewhere, Mac Jones threw two touchdowns to help the Jacksonville Jaguars defeat the Tennessee Titans 20-13, while the Las Vegas Raiders beat the New Orleans Saints 25-10.A homeless man on George St in Sydney. File photo: Getty Nationwide, rough sleeping increased by 22 percent with New South Wales, the hardest-hit state, witnessing a 51 percent surge since 2020, according to a landmark report released by the Australian Homelessness Monitor on Monday. The proportion of employed people accessing homelessness services jumped from 11 percent to 15.3 percent in the five years to 2022-23, which experts said showed the housing crisis had made sleeping rough no longer confined to the most vulnerable. Older Australians make up the fastest-growing cohorts of those affected by homelessness. People aged 55 to 64 jumped by 15 percent in the past six years, while persons aged 65 or older spiked by 31 percent. Under-the-pump homelessness agencies have seen a 12 percent rise in their monthly caseloads since 2019-20, and three-quarters of those services reported it was significantly harder to find housing for clients than just a year before. Lead report author Hal Pawson said unaffordable rent prices were heaping pressure on to services while forcing more people to sleep rough. Of those needing homelessness services in the three years to 2023-24, 36 percent cited housing affordability. "Median rents have increased 51 percent since the pandemic and there has been only a marginal expansion of social housing," Professor Pawson said. "Many support agencies are at a breaking point. Staff are operating in a completely clogged system. People exit support services into the same homelessness they were trying to escape." NSW's surge in rough sleeping has been driven by an increase in regional communities, the authors found. Homelessness Australia CEO Kate Colvin called for more investment in homelessness prevention, along with more funding for housing programs. "Homelessness is no longer confined to the most vulnerable ... with the housing crisis forcing working families into homelessness, this should be a wake-up call for action," she said. "Funding for homelessness services has failed to rise to meet demand ... governments need to take immediate action and deliver an emergency homelessness investment so that when people reach out for homelessness support there is someone there to help them."UCLA women’s basketball earns first-ever No. 1 ranking in weekly AP poll

Why I’m keeping my 2004 beater with 315,000 milesWhen will Ireland form its new Government?